An Exploratory Study of the Safety and Efficacy of BOTOX for the Treatment of Premature Ejaculation

Trial Profile

An Exploratory Study of the Safety and Efficacy of BOTOX for the Treatment of Premature Ejaculation

Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Oct 2016

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Premature ejaculation
  • Focus Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 03 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 03 Oct 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2017.
    • 03 Oct 2016 Planned number of patients changed from 60 to 74.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top